Sg3 Management, LLC Sage Therapeutics, Inc. Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $302,720 - $417,890	11,000 Added 220.0%	16,000 $517,000
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $1.15 Million - $1.71 Million	-37,500 Reduced 88.24%	5,000 $166,000
Q4 2021 Feb 15, 2022	BUY	$37.06 - $47.11 $222,360 - $282,660	6,000 Added 16.44%	42,500 $1.81 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $1.47 Million - $2.09 Million	36,500 New	36,500 $1.62 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.